Medical Devices
-
Ortho firms unfazed by Medicare joint replacement changes
Shifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.
By Elise Reuter • Aug. 11, 2026 -
Teledyne inks $1.1B takeover of Varex Imaging
Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.
By Nick Paul Taylor • Aug. 11, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
CMS seeks feedback on faster coverage for breakthrough devices
The proposed “RAPID” pathway could help some new medical devices get national Medicare coverage within months of FDA authorization.
By Susan Kelly • Aug. 11, 2026 -
Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
By Elise Reuter • Aug. 10, 2026 -
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
By Nick Paul Taylor • Aug. 10, 2026 -
Philips forms 6 patient monitoring partnerships
By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care continuity.
By Nick Paul Taylor • Aug. 7, 2026 -
Medtronic gets CE mark for ablation to treat ventricular tachycardia
Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.
By Susan Kelly • Aug. 7, 2026 -
Zimmer Biomet sales force revamp going better than expected, CEO says
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
By Elise Reuter • Aug. 6, 2026 -
Solventum plans software separation to become ‘true medtech company’
The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.
By Nick Paul Taylor • Aug. 6, 2026 -
Q&A
Medtronic on the future of AI-assisted surgery
Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.
By Susan Kelly • Aug. 5, 2026 -
BD recalls intraosseous needle sets associated with 4 deaths
Some needles were manufactured with incorrect dimensions, making it difficult to remove the stylet after placement.
By Elise Reuter • Aug. 5, 2026 -
STAAR Surgical appoints Warren Foust as permanent CEO
The implantable eye lens company began searching for a new CEO shortly after its sale to Alcon collapsed in January.
By Nick Paul Taylor • Aug. 5, 2026 -
DeepHealth gets FDA nod for AI tool that reads ultrasounds, creates reports
DeepHealth’s tool automates lesion detection, characterization and reporting from breast ultrasound scans.
By Elise Reuter • Aug. 4, 2026 -
Danaher promotes Julie Sawyer Montgomery to CEO
The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw the recent acquisition of Masimo.
By Susan Kelly • Aug. 4, 2026 -
Retrieved from Integer Holdings on August 03, 2026
KKR to take Integer private for $5.7B
Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.
By Elise Reuter • Aug. 3, 2026 -
Siemens Healthineers names new head of the Americas
The company disclosed the appointment of João Seabra the day before cutting its full-year sales outlook in response to continued challenges at its diagnostics division.
By Nick Paul Taylor • Aug. 3, 2026 -
Henry Schein removes 3 longtime execs in leadership shakeup
The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.
By Susan Kelly • Aug. 3, 2026 -
Medicare finalizes 2.3% hospital inpatient pay raise for 2027
Regulators also finalized the first nationwide, mandatory payment model to reduce the cost of joint replacements starting in 2028. Hospitals said the pay raise was inadequate, and chafed at the mandatory nature of the new model.
By Sydney Halleman • Aug. 3, 2026 -
Stryker catching up on orders, manufacturing after cyberattack
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.
By Elise Reuter • July 31, 2026 -
MMI to expand study of robotic microsurgery for Alzheimer’s
The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to restore drainage paths in the lymph nodes of Alzheimer's patients.
By Susan Kelly • July 31, 2026 -
Siemens Healthineers, Cleveland Clinic form 10-year alliance
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
By Nick Paul Taylor • July 31, 2026 -
Q&A
What J&J’s Ottava robot brings to the surgical table
Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different from the competition and how the healthcare giant plans to roll it out.
By Susan Kelly • July 30, 2026 -
Medtronic leads $37M investment in ablation mapping startup CoreMap
Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.
By Nick Paul Taylor • July 30, 2026 -
Abbott starts TriClip study amid rising competition for heart valve repair
Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.
By Nick Paul Taylor • July 29, 2026 -
Philips largely recoups struck-down Trump tariffs in Q2
The company recovered 186 million euros after it “largely completed the U.S. tariff refund process” in the quarter, CEO Roy Jakobs said on an earnings call.
By Nick Paul Taylor • July 28, 2026